Board Meeting Materials
Agenda Item IV. Discussion and Possible Action Related to Proposed Regulations, Title 16, California Code of Regulations Repeal of Sections 1708.3, 1708.4, 1735 et seq and 1751 et seq and Addition of Sections 1735 et seq, 1736 et seq, 1737 et seq, and 1738 et seq Related to Compounded Drug Preparations, Including Review of Any Comments Received During the 45–Day Comment Period and Regulation HearingBoard Staff Prepared Summarized Comments With Recommendations
Section 1735 et seq (Non–Sterile)
Section 1736 et seq (Sterile)
Section 1737 et seq (Hazardous)
Section 1738 et seq (Radiopharmaceuticals)
General Comments
- Board Staff Recommended Modified Text in Response to Comments Received for Consideration by the Board
- Written Comments Received
Agenda Item V. Proposed Amendment to CCR Section 1709.1 Related to Designation of PIC Including Review of Comments from the 15–Day Comment Period
Agenda Item VI. Approval of Board Meeting Minutes
Agenda Item VII. Department of Consumer Affairs Update
Agenda Item XI. Discussion and Consideration of the Board's Strategic Plan
Agenda Item XII. Enforcement Committee
Agenda Item XIII. Licensing Committee
Agenda Item XIV. Communication and Public Education Committee
Agenda Item XV. Legislation and Regulation Committee
Agenda Item XVI. Discussion of Proposed Issues to Raise as Part of Sunset Report
Agenda Item XVII. Organizational Committee Development Committee
Agenda Item XVIII. Executive Officer Report